Pillai Anitha A, Bhattacharya Rabindra Narayan, Radhakrishnan Vishnampet V, Banerjee Moinak
Rajiv Gandhi Centre for Biotechnology, Thycaud P,O, Thiruvananthapuram, Kerala, India.
J Carcinog. 2004 Jun 17;3(1):11. doi: 10.1186/1477-3163-3-11.
Astrocytic brain tumors are among the most lethal and morbid tumors of adults, often occurring during the prime of life. These tumors form an interesting group of cancer to understand the molecular mechanism of pathogenesis. Histological grading of Astrocytoma based on WHO classification does not provide complete information on the proliferation potential and biological behavior of the tumors. It is known that cancer results from the disruption of the orderly regulated cycle of replication and division. In the present study, we made an attempt to identify the cell cycle signatures and their involvement in the clinical aggressiveness of gliomas. METHODS: The variation in expression of various cell cycle genes was studied in different stages of glial tumor progression (low and high grades), and the results were compared with their corresponding expression levels in the normal brain tissue. Macroarray analysis was used for the purpose. RESULTS: Macroarray analysis of 114 cell cycle genes in different grades of glioma indicated differential expression pattern in 34% of the gene transcripts, when compared to the normal tissue. Majority of the transcripts belong to the intracellular kinase networks, cell cycle regulating kinases, transcription factors and transcription activators. CONCLUSION: Based on the observation in the expression pattern in low grade and high grade gliomas, it can be suggested that the upregulation of cell cycle activators are seen as an early event in glioma; however, in malignancy it is not the cell cycle activators alone, which are involved in tumorigenesis. Understanding the molecular details of cell cycle regulation and checkpoint abnormalities in cancer could offer an insight into potential therapeutic strategies.
星形胶质细胞脑肿瘤是成年人中最致命和病态的肿瘤之一,常发生在生命的黄金时期。这些肿瘤构成了一组有趣的癌症,有助于了解发病机制的分子机制。基于世界卫生组织(WHO)分类的星形细胞瘤组织学分级并不能提供关于肿瘤增殖潜能和生物学行为的完整信息。已知癌症是由有序调控的复制和分裂周期的破坏引起的。在本研究中,我们试图确定细胞周期特征及其与胶质瘤临床侵袭性的关系。
研究了胶质肿瘤进展不同阶段(低级别和高级别)各种细胞周期基因表达的变化,并将结果与正常脑组织中相应的表达水平进行比较。为此采用了基因芯片分析。
对不同级别胶质瘤中114个细胞周期基因的基因芯片分析表明,与正常组织相比,34%的基因转录本存在差异表达模式。大多数转录本属于细胞内激酶网络、细胞周期调节激酶、转录因子和转录激活剂。
基于对低级别和高级别胶质瘤表达模式的观察,可以认为细胞周期激活剂的上调是胶质瘤的早期事件;然而,在恶性肿瘤中,参与肿瘤发生的不仅仅是细胞周期激活剂。了解癌症中细胞周期调控和检查点异常的分子细节可能有助于深入了解潜在的治疗策略。